Invention Grant
- Patent Title: Triazine-oxadiazoles
- Patent Title (中): 三嗪 - 恶二唑
-
Application No.: US14054221Application Date: 2013-10-15
-
Publication No.: US08895733B2Publication Date: 2014-11-25
- Inventor: Oliver Barker , Jonathan Mark Bentley , Mark G. Bock , Thomas Cain , Praful Chovatia , Jennifer Ruth Dod , Florence Eustache , Laura Gleave , Jonathan Hargrave , Alexander Heifetz , Richard Law , Ali Raoof , David Willows
- Applicant: Oliver Barker , Jonathan Mark Bentley , Mark G. Bock , Thomas Cain , Praful Chovatia , Jennifer Ruth Dod , Florence Eustache , Laura Gleave , Jonathan Hargrave , Alexander Heifetz , Richard Law , Ali Raoof , David Willows
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Joshua Roth
- Main IPC: C07D413/04
- IPC: C07D413/04 ; C07D413/14 ; A61K31/53 ; A61P29/00 ; A61K45/06 ; C07D498/08 ; C07D491/10 ; C07D451/02 ; C07D491/107 ; C07D417/14 ; C07D487/04
Abstract:
The invention relates to new derivatives of formula (I), wherein the substituents are as defined in the specification; to processes for the preparation of such derivatives; pharmaceutical compositions comprising such derivatives; such derivatives as a medicament; such derivatives for the treatment of chronic pain.
Public/Granted literature
- US20140051676A1 Triazine-oxadiazoles Public/Granted day:2014-02-20
Information query
